Android
Zerodha Broker (Free Delivery)

India's No. 1 Broker with Best Software Trade @ Flat Rs 20

Open Instant Account

TORRENT PHARMACEUTICALS LTD.2615.10 -0.60 (-0.02%)

  • BSE: 500420
  • |
  • NSE: TORNTPHARM
  • |
  • ISIN NO: INE685A01028
  • |
  • INDUSTRY: Pharmaceuticals
Profile

TORNTPHARM

Torrent Pharmaceuticals or TORNTPHARM

It was started in 1959 by U N Mehta as Trinity Laboratories, and then the company changed its name to the one used currently in the year 1971. TPL is the flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has a presence in gastrointestinal, diabetology, and the sections of pain management.

Some of the Manufacturing facilities:

Its prime manuf ... acturing facilities are located at Indrad (Gujarat), and Baddi (Himachal Pradesh) and these units have received many certifications for its quality management such as ISO 9001, ISO 14001 and OHSAS 18001, and ISO/IEC– 17025 and more. The company's manufacturing plant in Indrad produces a bulk of drugs, APIs, the formulation in the form of tablets, capsules, and vials. The annual production capacity of this particular plant is 6000 million kg of formulations and 15000 kg of bulk drugs/APIs. Whereas the Baddi plant has a manufacturing capacity of approximately 3600 million tablets, 400 million capsules, and 18 million oral liquid bottles p. a. In India, this particular company has at least 11 sales and marketing divisions and 1000 product registrations across 50 different countries that include US Latin America, Russia, Europe, Japan, and others. Its research and development department consists of a team of 560 scientists who are continuously engaged in drug discovery, drug development, and new drug delivery systems. Its subsidiaries are Zao Torrent Pharma in Russia, Torrent Do Brasil Ltda in Brazil, Torrent Pharma GmbH in Germany, Torrent Pharma Inc. in USA and Torrent Pharma Philippines Inc. in Philippines.

Some of the Awards:

  1. 2002–03: The Torrent Pharma bagged the Gold Trophy for IDMA and Quality Excellence Award 2003 for both Formulations and API manufacturing facilities.
  2. 2001–02: The Torrent Pharmaceuticals bagged the 'Best Suppliers' award by the Sri Lankan State Pharmaceutical Corporation.
  3. 2001–02: The Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award for its Formulations facility and Silver Trophy for its API manufacturing facility.
  4. 2000–01: The Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award for its Formulations facility.
  5. 1999–00: GCCI Export Appreciation Award
  6. 1999–00: The Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award for its Formulations facility.
  7. 1992–93: It received the IDMA Quality Excellence Award
  8. 1991–92: It received Export Award from Govt. of Gujarat
  9. 1991–92: It won the National Export Award
  10. 1990–91: It received Export Award from Govt. of Gujarat
  11. 1990–91: The Pride of Asia International award for excellence in Pharmaceuticals Products by international Friendship

The Milestones:

  1. 2011: Received USFDA approval for Alfuzosin hydrochloride other extended-release tablets.
  2. 2006: The API and formulations manufacturing facilities, which are located at Indrad (Gujarat, India) got the US FDA approval.
  3. 2006: It entered into an in-licensing deal with Tasly of China to market its Cardiotonic pill in India.
  4. 2006: The Torrent Pharma Japan Co., Ltd. incorporated in Japan.
  5. 2005: Torrent Australasia Pty Ltd. included in Australia.
  6. 2005: The new manufacturing unit at Baddi, Himachal Pradesh, set up to cater to the domestic formulations market.
  7. 2005: It signed an agreement with Novo Nordisk India to establish a new, dedicated formulation and with the packaging facility for Insulin, exclusively for Novo Nordisk.
  8. 2005: The Company acquired Heumann Pharma GmbH & Co Generica KG, a Pfizer group company, in Germany.
  9. 2005: Two new marketing divisions such as AXON and NEURON, set up to cater to the neuropsychiatry section.
  10. 2005: The Company entered into the research collaboration with AstraZeneca for developing novel antihypertensive drug.
  11. 2004: The Torrent Pharma Philippines Inc. was set up.

Read More
Key Data
  • Market cap 39979.00 CR.
  • Book value 302.62
  • Stock P/E 47
  • Dividend Yield 0.72%
  • ROCE 13.09%
  • ROE 14.93%
  • Sales Growth (3Y) 1.94%
  • Face Value (3Y) 5.00
Trend Analysis
  • Short Term Trend :
    Down
  • Medium Term Trend :
    Not Clear
  • Long Term Trend :
    Not Clear

Are you friends with trend?

There is a saying in stock market, "Trend is your best friend"

It means, a good trader doesn't place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

Day Technicals

What is Opening Range Breakout?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

NR7

What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

Opening Price clues

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn't allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

Day High Low Range
TIME LOWEST HIGHEST
10 AM - -
11 AM - -
12 PM - -
1 PM - -
2 PM - -
Japanese Candlestick Patterns
Candle Pattern 1 :Doji
Candle Pattern 2 : None
Candle Pattern 3 :None
Candlestick Price Action
Higher High Higher Low
Pivot Points
Name S4 S3 S2 S1 Pivot Points R1 R2 R3 R4
classic 2408.13 2471.98 2535.83 2560.32 2599.68 2624.17 2663.53 2727.38 2791.23
woodie's 2475.37 2539.22 2557.21 2603.08 2621.06 2666.92 2684.91 2730.78 2794.62
fibonacci - 2535.83 2560.21 2575.29 2599.68 2624.07 2639.16 2663.53 -
camarilla 2549.68 2567.24 2573.09 2578.95 -- 2590.65 2596.51 2602.36 2619.92
Past Performance & Moving Averages
Day’s LOW HIGH RANGE SMA PERFORMANCE Nifty
10 DAY 2565.00
2747.80
2634.68 -0.88 % 1.48 %
20 DAY 2418.75
2747.80
2597.92 3.26 % 5.01 %
50 DAY 2418.75
2944.50
2680.39 -6.97 % 10.14 %
100 DAY 2231.85
3031.20
2672.30 -6.08 % 13.98 %
200 DAY 1583.25
3031.20
2478.28 7.07 % 40.86 %
YTD 1583.25
3031.20
2410.06 42.15 % 6.75 %
52 Week 1452.00
3031.20
2143.57 41.33 % 7.33 %

Why are moving Averages important in technical Analysis?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

Gaps On Day Chart
Industry Growth Rate

In Last 1 Year the industry has grown by 11.93 %

In Last 5 Year the industry has grown by 12.41 %

Peer comparison

Sales

COMPANY NAME 2014 2015 2016 2017 2018 2019
TORNTPHARM 4172.00 4636.00 6687.00 5816.00 5950.00 7673.00
SUNPHARMA 16080.00 27392.00 28487.00 31578.00 26489.00 29066.00
LUPIN 11286.00 12770.00 14256.00 17367.00 15797.00 16718.00
CIPLA 10173.00 11345.00 13790.00 14394.00 15156.00 16362.00
AUROPHARMA 8089.00 12103.00 13772.00 14910.00 16463.00 19564.00
Total 9960.00 13649.20 15398.40 16813.00 15971.00 17876.60

Financial

LAST FISCAL CURRENT GROWTH 10 YEAR CAGR
S.NO. COMPANY NAME MARKET CAP CMP BOOK VALUE EPS STOCK P/E ROE ICR REVENUE NET PROFIT NPM REVENUE NET PROFIT REVENUE NET PROFIT
1 SUN PHARMACEUTICAL INDUSTRIES LTD. 122752.80 511.55 98.33 11.11 38.37 11.10 11.45% 29066.00 2665.00 9.17% 9.73% 27.15% 21.39% 3.90%
2 MARKSANS PHARMA LTD. 92969.02 22.65 11.85 1.87 10.83 1.85 13.20% 1000.00 76.00 7.60% 9.53% 130.30% 10.88%
3 MOREPEN LABORATORIES LTD. 71575.87 15.90 6.43 0.64 23.05 0.32 34.00% 769.00 29.00 3.77% 26.69% 15.56%
4 NEULAND LABORATORIES LTD. 50071.35 390.75 542.16 12.74 36.68 1.23 3.63% 667.00 16.00 2.40% 26.57% 33.33% 8.07% 2.92%
5 GUFIC BIOSCIENCES LTD. 41419.69 53.30 10.85
6 DIVI'S LABORATORIES LTD. 95729.13 3607.60 266.77 50.96 38.52 25.53 374.60% 4946.00 1353.00 27.36% 27.11% 54.28% 15.41% 12.49%
7 DR.REDDY'S LABORATORIES LTD. 80237.95 4829.60 852.69 117.47 26.67 23.49 35.71% 15448.00 1950.00 12.62% 8.17% 105.91% 8.45%
8 RPG LIFE SCIENCES LTD. 41788.21 252.45 105.02
9 SMS PHARMACEUTICALS LTD. 34236.68 40.25 42.07 4.73 8.97 5.00 7.50% 465.00 40.00 8.60% 0.43% 25.00%
10 CIPLA LTD. 60016.24 744.65 209.71 18.96 23.60 9.49 18.43% 16362.00 1528.00 9.34% 7.96% 8.29% 12.67% 7.08%
11 TORRENT PHARMACEUTICALS LTD. 44206.01 2611.10 323.66 25.78 77.62 5.13 3.86% 7673.00 436.00 5.68% 28.96% 16.89% 9.01%
12 PIRAMAL ENTERPRISES LTD. 31277.26 1386.70 823.58 70.51 20.69 39.81 1.61% 13215.00 1473.00 11.15% 24.31% 15.08% 16.64%
13 LUPIN LTD. 40409.34 891.80 384.76 13.40 53.92 6.74 9.28% 16718.00 607.00 3.63% 5.83% 141.83% 16.04% 1.92%
14 NECTAR LIFESCIENCES LTD. 29495.44 13.16 49.89 2.12 6.56 2.18 1.78% 2779.00 48.00 1.73% 48.29% 14.38%
15 AUROBINDO PHARMA LTD. 50837.31 868.05 206.07 40.36 12.59 40.08 15.03% 19564.00 2365.00 12.09% 18.84% 20.53% 37.21%
16 Alkem Laboratories Ltd 33998.24 2832.00 501.34 63.61 37.53 31.71 20.36% 7357.00 761.00 10.34% 14.94% 20.60%
17 ABBOTT INDIA LTD. 32830.92 15397.55 1004.00
18 CADILA HEALTHCARE LTD. 46096.93 450.10 90.85 18.05 15.05 18.13 15.32% 13166.00 1849.00 14.04% 10.59% 4.11% 16.49% 19.83%
19 GLAXOSMITHKLINE PHARMACEUTICALS LTD. 26390.95 1558.20 138.61 26.29 52.38 2.63 581.00% 3128.00 445.00 14.23% 8.95% 26.78%
20 KILITCH DRUGS (INDIA) LTD. 13893.00 89.90 98.74 2.49 51.55 0.25 11.22% 82.40 3.83 4.65% 61.70%
Sales

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.

Profitability

What is Profit & EPS Trend ?

EPS Trends was initially built in late 2015 when I was just getting into frontend development. Coming from a background in Rails, I was frustrated with how many decisions you had to make early on as a javascript developer.

Net Profit
EPS

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBITDA Margin
EBIT Margin
NPM
Cash Flow

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Operating Activities
Financing Activities
Investing Activities
Financial Health

What Is Financial Health?

Financial health is a term used to describe the state of one's personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity
Piotroski Score
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firm's financial position.

Altman Z Score (Mfg Company)
  • Distress (< 1.81)
  • Caution (>1.81 < 2.99)
  • 7.42
    Safe (3 & above)
Altman Z Score (Non-Mfg Company)
  • Distress ( < 1.23)
  • Caution (>1.23 < 2.6)
  • 12.34
    Safe (2.6 & above)
Valuation

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.

TORNTPHARM: Future
TRADING SYMBOL OI VOLUME LAST PRICE LOT SIZE EXPIRY DATE
TORNTPHARM20DECFUT 892750.00 575000.00 2625.00 250 2020-12-31
TORNTPHARM21JANFUT 19500.00 5250.00 2628.55 250 2021-01-28
TORNTPHARM21FEBFUT 2400.00 0.00 0.00 250 2021-02-25
ROLLOVER COST: 0.14% (INR 3.55)
ROLLOVER%:2.39%
What is the significance of Rollover data?

Rollover in an important data point and should be analyzed in the expiry week. Rollover involves carry forwarding of ‘futures’ positions from one series (which is nearing expiry date) to the next one.

Rollover percentage actually indicates whether the traders are willing to carry forward their existing. positions (long or short) to the next series or not. Generally, the rollover figures alone will not indicate which direction traders are betting on. You should also check whether absolute open interest is increasing or decreasing over expiries

What is Options Max Pain Theory?

Options Max Pain Theory suggests,

“On option expiration day, the underlying stock price often moves toward a point that brings maximum loss to option buyers.”

Ratio Analysis

The Bank was incorporated in the year 2004 by Rana Kapoor and Late Ashok Kapur, which is a new age private sector bank. And since the inception of the bank has fructified into a “Full-Service Commercial Bank,” it has steadily built Corporate and Institutional Banking, Financial Markets, Investment Banking, Corporate Finance, Branch Banking, Business and Transaction Banking, and Wealth Management business lines across the whole country.

It is well-equipped to offer a spectrum of products and services to all the corporate and retail customers.

Read More
Bulk Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
TORNTPHARM 2018-06-15 LAVENDER INVESTMENTS LIMITED S 901207.00 1475.08
TORNTPHARM 2017-03-28 ANITA SUDHIR MEHTA S 6120168.00 1401.00
TORNTPHARM 2017-03-28 JINAL SUDHIRBHAI MEHTA S 1752900.00 1401.00
TORNTPHARM 2017-03-28 SAMIR U MEHTA HUF S 2079900.00 1401.00
TORNTPHARM 2017-03-28 SAMIR UTTAMLAL MEHTA S 6283860.00 1401.00
TORNTPHARM 2017-03-28 SUDHIR U MEHTA HUF S 1717380.00 1401.00
TORNTPHARM 2017-03-28 TORRENT PRIVATE LIMITED P 19704108.00 1401.00
TORNTPHARM 2017-03-28 VARUN SUDHIRBHAI MEHTA S 1749900.00 1401.00
TORNTPHARM 2010-06-02 GMO EMERGING MARKETS FUND P 780900.00 566.00
TORNTPHARM 2010-06-02 GPC MAURITIUS II LLC S 3920993.00 566.00
TORNTPHARM 2008-06-17 TORRENT PRIVATE LIMITED P 2582080.00 157.84
TORNTPHARM 2008-06-17 U N MEHTA HUF S 1719448.00 154.30
TORNTPHARM 2008-06-17 U N MEHTA HUF NO 2 S 862632.00 164.90
TORNTPHARM 2007-11-20 ICICI SECURITIES PRIMARY DEALERSHIP LTD P 500000.00 190.00
TORNTPHARM 2007-11-20 TEMPLETON MUTUAL FUND AC FRANKLIN INDIA PRIMA PLUS AC 4616 S 500000.00 190.00
TORNTPHARM 2007-10-05 MAVI INVESTMENT FUND LTD S 2600000.00 186.00
TORNTPHARM 2005-12-27 DEUTSCEH INTERNATIONAL TR S 650000.00 835.00
TORNTPHARM 2005-12-27 MAVI INVESTMENT FUND LIMI P 650000.00 835.00
TORNTPHARM 2005-12-21 DEUTSCHE INTL TRUST CORPO S 430000.00 830.00
TORNTPHARM 2005-12-21 LOTUS GLOBAL INVESTMENTS P 430000.00 830.03
TORNTPHARM 2005-12-16 DITC C I LTD DBMGOF MAUR S 420000.00 861.50
TORNTPHARM 2005-12-16 LOTUS GLOBAL INVESTMENTS P 420000.00 861.52
Block Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
TORNTPHARM 2017-03-28 TORRENT PRIVATE LIMITED P 6283860.00 1401.00
TORNTPHARM 2017-03-28 TORRENT PRIVATE LIMITED P 6120168.00 1401.00
TORNTPHARM 2017-03-28 TORRENT PRIVATE LIMITED P 2079900.00 1401.00
TORNTPHARM 2017-03-28 TORRENT PRIVATE LIMITED P 1752900.00 1401.00
TORNTPHARM 2017-03-28 TORRENT PRIVATE LIMITED P 1749900.00 1401.00
TORNTPHARM 2017-03-28 TORRENT PRIVATE LIMITED P 1717380.00 1401.00
TORNTPHARM 2017-03-28 VARUN SUDHIRBHAI MEHTA S 1749900.00 1401.00
TORNTPHARM 2017-03-28 ANITA SUDHIR MEHTA S 6120168.00 1401.00
TORNTPHARM 2017-03-28 JINAL SUDHIRBHAI MEHTA S 1752900.00 1401.00
TORNTPHARM 2017-03-28 SAMIR UTTAMLAL MEHTA S 6283860.00 1401.00
TORNTPHARM 2017-03-28 SUDHIR U MEHTA HUF S 1717380.00 1401.00
TORNTPHARM 2017-03-28 SAMIR U MEHTA HUF S 2079900.00 1401.00
TORNTPHARM 2008-06-17 U N MEHTA HUF NO 2 S 862632.00 164.90
TORNTPHARM 2008-06-17 U N MEHTA HUF S 1719448.00 154.30
TORNTPHARM 2008-06-17 TORRENT PRIVATE LIMITED P 2582080.00 157.84
TORNTPHARM 2007-10-05 ICICI SECURITIES PRIMARY DEALERSHIP LTD P 2600000.00 186.00
TORNTPHARM 2007-10-05 MAVI INVESTMENT FUND LTD S 2600000.00 186.00
Dividend history
Ex Date Amount
2020-03-18 17.00
2020-03-18 15.00
2019-06-13 4.00
2019-02-06 13.00
2018-06-18 5.00
2018-02-15 9.00
2017-06-19 4.00
2017-02-10 10.00
2016-03-16 15.00
2016-02-11 20.00
2015-06-15 6.25
2015-02-02 5.00
2014-06-16 5.00
2014-01-24 5.00
2013-06-10 7.00
2013-06-10 10.00
2013-02-01 6.00
2012-06-11 2.50
2012-01-27 6.00
2011-06-06 6.00
2011-06-06 2.00
2010-06-04 6.00
2009-06-08 4.00
2008-06-19 3.50
2001-05-28 7.50
Bonus Data
Company Name Split Date From Value To Value
TORRENT PHARMACEUTICALS LTD. 2013-07-23 1.00 1.00
Split Data
Company Name Split Date From Value To Value